Fungal Infection Testing + Diagnostics for Human Health

Since 2002, MiraVista Diagnostics has been developing and evolving our menu of diagnostic tests for fungal infections. We work with hospital labs, research university labs, government and municipal labs, physician practices, large reference labs and CROs across the country to detect, analyze and monitor a wide range of serious mycology infections that afflict their patients. This includes antigen and antibody detection tests for aspergillus, blastomyces dermatitidis, histoplasma capsulatum, coccidioides, cryptococcus and beta-D-glucan.

Accurate Test Results Lead to Better Patient Outcomes

MiraVista Diagnostics understands the critical role we play in the health care and health science continuum. Because we take that responsibility seriously, we are committed to partnering with clinicians to consistently deliver:

  • Superior clinical standards in testing accuracy and sensitivity
  • Rapid response and test results
  • Dedication to excellent client service and customer satisfaction
  • Direct access to our infectious disease experts
  • Quality assurance across our organization
  • Compliance with regulatory mandates and industry best practices
  • Continuous product and service improvement
Company News

American College of Chest Physicians Boston, MA October 6-9, 2024

MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT                                        This event will bring you the most up-to-date education in clinical pulmonary, critical care,…
READ MORE →

ID WEEK Los Angeles, CA October 16-20, 2024

MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT                                   Surround yourself with the ID experts who are advancing the field of ID. Choose scientific programming that’s…
READ MORE →

MiraVista Institutional Biosafety Committee (IBC) Announcement

In compliance with NIAID/NIH guidelines research at MiraVista Diagnostics utilizing synthetic or recombinant DNA is annually reviewed by the MiraVista Institutional Biosafety Committee (IBC). The IBC is made up of internal and external subject matter experts to ensure that MiraVista…
READ MORE →

Pulmonary Histoplasmosis: A Clinical Update – Published

MiraVista Diagnostics’ article “Pulmonary Histoplasmosis: A Clinical Update” has been published in “Journal of Fungi” as part of the Special Issue “Diagnosis and Treatment of Invasive Pulmonary Fungal Infections.” Read the article. View the PDF.    

PAST EVENT: American Transplant Congress 2024 Philadelphia, PA June 1-5, 2024

MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT                                      The American Transplant Congress (ATC) brings together the people and organizations who are redefining the…
READ MORE →

PAST EVENT: Coccidioides Study Group San Antonio, TX April 5-6, 2024

MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT                                      The 68th Annual Coccidioidomycosis Study Group will take place April 5th-April 6th, 2024 in San…
READ MORE →

ORDER TESTS
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo